The study, published Monday in the journal Nature Medicine, is one of the first big-picture looks at the benefits and risks of these new drugs, which rapidly made an impact on health care, insurance coverage, the grocery industry, and even the economy of an entire country (Denmark, where Novo Nordisk, the maker of Ozempic and Wegovy is based.) These drugs have also been given partial credit for a recent dip in obesity rates in the US, which dropped in 2023 for the first time in over a decade
Supplied strictly for in-vitro laboratory research
Because the article treats animal data as mechanistic rather than predictive
[DOI] [PubMed] [Google Scholar] 9.Ruggieri M., Huson S.M
Interestingly, Faecalibacterium served as a primary butyrate-producing bacterium in the gut, being crucial for gut homeostasis and possibly alleviating depressive symptoms at least in animal models (Stilling et al., 2016)
Drfr kan testresultaten vara svra att tolka och har i regel begrnsat kliniskt vrde utan medicinsk sammanhangsbedmning
